Abstract
The 13-valent pneumococcal conjugate vaccine (Prevnar 13) was first recommended for use in older adults (age, ≥65; NEJM JW Gen Med Apr 1 2015 and Ann
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
